Literature DB >> 23832534

Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjects.

Josephine M Forbes1, Karly C Sourris, Maximilian P J de Courten, Sonia L Dougherty, Vibhasha Chand, Jasmine G Lyons, David Bertovic, Melinda T Coughlan, Markus P Schlaich, Georgia Soldatos, Mark E Cooper, Nora E Straznicky, Bronwyn A Kingwell, Barbora de Courten.   

Abstract

It has been postulated that chronic exposure to high levels of advanced glycation end products (AGEs), in particular from dietary sources, can impair insulin secretion. In the present study, we investigated the cross-sectional relationship between AGEs and acute insulin secretion during an intravenous glucose tolerance test (IVGTT) and following a 75 g oral glucose tolerance test (OGTT) in healthy humans. We report the cross-sectional association between circulating AGE concentrations and insulin secretory function in healthy humans (17 F: 27 M, aged 30 ± 10 years) with a wide range of BMI (24.6-31.0 kg/m(2)). Higher circulating concentrations of AGEs were related to increased first phase insulin secretion during IVGTT (r = 0.43; p < 0.05) and lower 2-h glucose concentrations during OGTT (r = -0.31; p < 0.05). In addition, fasting (r = -0.36; p < 0.05) and 2-h glucose concentrations were negatively related to circulating levels of soluble receptor for AGE (RAGE) isoforms (r = -0.39; p < 0.01). In conclusion, in healthy humans, we show a cross-sectional association between advanced glycation end products and acute insulin secretion during glucose tolerance testing.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23832534     DOI: 10.1007/s00726-013-1542-9

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  12 in total

Review 1.  Dietary Advanced Glycation End Products and Cardiometabolic Risk.

Authors:  Claudia Luévano-Contreras; Armando Gómez-Ojeda; Maciste Habacuc Macías-Cervantes; Ma Eugenia Garay-Sevilla
Journal:  Curr Diab Rep       Date:  2017-08       Impact factor: 4.810

2.  Dietary intake of advanced glycation end products (AGEs) and changes in body weight in European adults.

Authors:  R Cordova; V Knaze; V Viallon; P Rust; C G Schalkwijk; E Weiderpass; K-H Wagner; A-L Mayen-Chacon; E K Aglago; C C Dahm; K Overvad; A Tjønneland; J Halkjær; F R Mancini; M-C Boutron-Ruault; G Fagherazzi; V Katzke; T Kühn; M B Schulze; H Boeing; A Trichopoulou; A Karakatsani; P Thriskos; G Masala; V Krogh; S Panico; R Tumino; F Ricceri; A Spijkerman; J Boer; G Skeie; C Rylander; K B Borch; J R Quirós; A Agudo; D Redondo-Sánchez; P Amiano; J-H Gómez-Gómez; A Barricarte; S Ramne; E Sonestedt; I Johansson; A Esberg; T Tong; D Aune; K K Tsilidis; M J Gunter; M Jenab; Heinz Freisling
Journal:  Eur J Nutr       Date:  2019-11-07       Impact factor: 5.614

3.  Use of carnosine in the prevention of cardiometabolic risk factors in overweight and obese individuals: study protocol for a randomised, double-blind placebo-controlled trial.

Authors:  Kirthi Menon; James D Cameron; Maximilian de Courten; Barbora de Courten
Journal:  BMJ Open       Date:  2021-05-13       Impact factor: 2.692

4.  Effect of advanced glycosylation end products on apoptosis in human adipose tissue-derived stem cells in vitro.

Authors:  Zhe Wang; Hongqiu Li; Dianbao Zhang; Xiaoyu Liu; Feng Zhao; Xining Pang; Qiushi Wang
Journal:  Cell Biosci       Date:  2015-01-27       Impact factor: 7.133

5.  Association between Advanced Glycation End Products and Impaired Fasting Glucose: Results from the SALIA Study.

Authors:  Tom Teichert; Anne Hellwig; Annette Peßler; Michael Hellwig; Mohammad Vossoughi; Dorothea Sugiri; Andrea Vierkötter; Thomas Schulte; Juliane Freund; Michael Roden; Barbara Hoffmann; Tamara Schikowski; Christian Luckhaus; Ursula Krämer; Thomas Henle; Christian Herder
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

Review 6.  Can insulin signaling pathways be targeted to transport Aβ out of the brain?

Authors:  Milene Vandal; Philippe Bourassa; Frédéric Calon
Journal:  Front Aging Neurosci       Date:  2015-06-16       Impact factor: 5.750

7.  Muscle Carnosine Is Associated with Cardiometabolic Risk Factors in Humans.

Authors:  Barbora de Courten; Timea Kurdiova; Maximilian P J de Courten; Vitazoslav Belan; Inge Everaert; Marek Vician; Helena Teede; Daniela Gasperikova; Giancarlo Aldini; Wim Derave; Jozef Ukropec; Barbara Ukropcova
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

8.  High Serum Advanced Glycation End Products Are Associated with Decreased Insulin Secretion in Patients with Type 2 Diabetes: A Brief Report.

Authors:  Tsuyoshi Okura; Etsuko Ueta; Risa Nakamura; Yohei Fujioka; Keisuke Sumi; Kazuhisa Matsumoto; Kyoko Shoji; Kazuhiko Matsuzawa; Shoichiro Izawa; Yuri Nomi; Hitomi Mihara; Yuzuru Otsuka; Masahiko Kato; Shin-Ichi Taniguchi; Kazuhiro Yamamoto
Journal:  J Diabetes Res       Date:  2017-06-12       Impact factor: 4.011

Review 9.  Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance.

Authors:  Mona S Ottum; Anahita M Mistry
Journal:  J Clin Biochem Nutr       Date:  2015-07-01       Impact factor: 3.114

10.  Does supplementation with carnosine improve cardiometabolic health and cognitive function in patients with pre-diabetes and type 2 diabetes? study protocol for a randomised, double-blind, placebo-controlled trial.

Authors:  Estifanos Baye; Kirthi Menon; Maximilian Pj de Courten; Arul Earnest; James Cameron; Barbora de Courten
Journal:  BMJ Open       Date:  2017-09-01       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.